Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Hospital Topics|July 1, 1978
Improved supervision through better communicationH Munn
Dental Management|January 1, 1985
Disability insurance: find the plan that fits your needsH Munn
Current Opinion in Immunology|February 8, 2006
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulationDavid H Munn
Annals of the New York Academy of Sciences|June 26, 2002
Tolerogenic antigen-presenting cellsDavid H Munn
Current Medicinal Chemistry|April 27, 2011
Indoleamine 2,3-dioxygenase, Tregs and cancerD H Munn
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Blocking IDO activity to enhance anti-tumor immunityDavid H Munn
Blood|August 8, 2009
Th17 cells in ovarian cancerDavid H Munn
The Journal of Clinical Investigation|January 17, 2018
The host protecting the tumor from the host - targeting PD‑L1 expressed by host cellsDavid H Munn
European Journal of Immunology|January 28, 2010
Lineage-specific transcription factors in unexpected placesDavid H Munn
Journal of Internal Medicine|November 22, 2007
Animal research: the debate continuesD Weatherall, H Munn
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Hospital Topics|July 1, 1978
Improved supervision through better communicationH Munn
Dental Management|January 1, 1985
Disability insurance: find the plan that fits your needsH Munn
Current Opinion in Immunology|February 8, 2006
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulationDavid H Munn
Annals of the New York Academy of Sciences|June 26, 2002
Tolerogenic antigen-presenting cellsDavid H Munn
Current Medicinal Chemistry|April 27, 2011
Indoleamine 2,3-dioxygenase, Tregs and cancerD H Munn
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Blocking IDO activity to enhance anti-tumor immunityDavid H Munn
Blood|August 8, 2009
Th17 cells in ovarian cancerDavid H Munn
The Journal of Clinical Investigation|January 17, 2018
The host protecting the tumor from the host - targeting PD‑L1 expressed by host cellsDavid H Munn
European Journal of Immunology|January 28, 2010
Lineage-specific transcription factors in unexpected placesDavid H Munn
Journal of Internal Medicine|November 22, 2007
Animal research: the debate continuesD Weatherall, H Munn
Pageof 19